BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 20, 2018
View Archived Issues
EDELWEISS phase IIb study of linzagolix achieves primary and secondary endpoints
Read More
NINDS grant supports AcuraStem's work in ALS
Read More
WindMIL Therapeutics completes series B financing to support development of MILs
Read More
DGKZ regulates muscle mass in remodeling and may be a target of therapies against muscle wasting
Read More
Kazia Therapeutics presents preliminary phase I data for Cantrixil
Read More
Marinus Pharmaceuticals initiates pivotal phase III Marigold Study of ganaxolone
Read More
Positive interim phase II data presented for LB-1148 in patients undergoing major surgery
Read More
FDA grants regenerative medicine advanced therapy designation to CD34+ cell therapy
Read More
RC-48-ADC demonstrates promising antitumor activity in patients with metastatic breast cancer
Read More
Boehringer Ingelheim identifies free fatty acid receptor 1 agonists
Read More
Allena Pharmaceuticals completes preclinical proof-of-concept study for ALLN-346
Read More
Genentech, Roche and Paraza Pharma patent TRPA1 antagonists
Read More
Andes-1537 well tolerated in phase I study, dose expansions planned
Read More
Monalizumab shows promising activity in combination with durvalumab in MSS-CRC
Read More
Seattle Children's initiates phase I trial of CAR T-cell therapy for pediatric CNS tumors
Read More
Can-Fite updates status of phase II trial of namodenoson in advanced HCC
Read More
Kala updates registration plan for KPI-121 for short-term treatment of dry eye disease
Read More
Idorsia initiates phase III study of aprocitentan for resistant hypertension
Read More
Tumor mutations can aid variant calling for germline
Read More
Clinical benefit noted with NIR-178 in patients with non-small cell lung cancer
Read More
Argenx reports cohort 1 interim data from phase II study of efgartigimod in pemphigus vulgaris
Read More
IDMC recommends continuation of phase III study of masitinib for metastatic CRPC
Read More
Sarepta reports preliminary data from phase I/IIa gene therapy trial in Duchenne muscular dystrophy
Read More
ACY-1215 in combination with nab-paclitaxel shows promising activity in metastatic breast cancer
Read More
CStone initiates phase I trial in Australia with MEK inhibitor CS-3006
Read More